For people undergoing in vitro fertilization (IVF), understanding embryo development and genetic testing can help make treatment decisions easier. One test that fertility specialists may discuss is Preimplantation Genetic Testing for Aneuploidy (PGT-A), which screens embryos for an abnormal number of chromosomes before embryo transfer.
Human cells typically contain 46 chromosomes arranged in 23 pairs. Sometimes, an embryo develops with extra or missing chromosomes, a condition known as aneuploidy. These chromosome differences can affect embryo development and may contribute to implantation failure or miscarriage.
PGT-A provides additional information about an embryo's chromosome status. However, it is a screening tool, not a guarantee of pregnancy or the birth of a healthy baby.
How Does PGT-A Work?
PGT-A is performed during an IVF cycle after embryos have developed to the blastocyst stage, usually around day five or six.
The process generally involves the following steps:
Egg retrieval and fertilization: Eggs are collected and fertilized with sperm in a laboratory.
Embryo development: The embryos are monitored as they grow to the blastocyst stage.
Embryo biopsy: A small number of cells are collected from the outer layer of the embryo.
Embryo freezing: The embryos are usually frozen while the samples undergo testing.
Laboratory analysis: Specialists analyze the samples and report the chromosome findings.
The results can help the fertility team discuss which embryos may be suitable for transfer. Because the biopsy examines only a small sample of cells, the results may not always represent every cell in the embryo.
Understanding IVF success rates can also help patients discuss realistic treatment expectations with their fertility team
When Might a Fertility Specialist Recommend PGT-A?
PGT-A may be discussed in several situations, depending on a person's medical history and treatment goals.
Advanced Maternal Age
The likelihood of chromosome abnormalities in embryos generally increases with age. For some patients, particularly those undergoing IVF at an older reproductive age, PGT-A may provide useful information when selecting embryos for transfer.
Repeated IVF Failure or Pregnancy Loss
People who have experienced unsuccessful embryo transfers or recurrent pregnancy loss may discuss genetic testing with their fertility specialist. Chromosomal abnormalities are one possible factor, although other medical and reproductive factors can also contribute.
Previous Chromosomal Abnormalities
A previous pregnancy or embryo affected by a chromosome abnormality may influence discussions about testing in a future IVF cycle. The appropriate testing strategy depends on the specific condition and family history.
When the Benefits May Be Unclear
PGT-A may not provide the same benefit for every patient. For example, when only a small number of embryos are available, the potential value of testing must be weighed against its cost, limitations, and the possibility that no embryo will be classified as suitable for transfer.
A fertility specialist can help patients understand whether testing is appropriate for their circumstances.
PGT-A vs. PGT-M: What Is the Difference?
Although both tests are used in reproductive genetics, they answer different questions.
PGT-A: Screens embryos for an abnormal number of chromosomes.
PGT-M: Tests for a specific inherited genetic condition when a relevant gene variant is known or suspected.
PGT-A does not screen for every genetic disease. Patients with a family history of an inherited condition may need a different testing approach, which should be discussed with a genetic specialist.
Understanding PGT-A Results
Laboratories commonly classify results into several categories:
Euploid: The tested cells show the expected number of chromosomes.
Aneuploid: The tested cells show an extra or missing chromosome.
Mosaic: The sample suggests a mixture of cells with different chromosome findings.
Inconclusive: The test did not provide a clear result.
These findings require careful interpretation. Some mosaic embryos may be considered for transfer in selected circumstances, but the decision requires individualized counseling and review of the laboratory report.
A euploid result also does not guarantee implantation, pregnancy, or a healthy birth. Embryo development, uterine factors, and other aspects of reproductive health continue to influence outcomes.
What Does PGT-A Cost?
The total cost varies according to the fertility clinic, laboratory, number of embryos tested, and services included in the treatment package.
Patients should ask whether the quoted price includes embryo biopsy, laboratory analysis, embryo freezing, storage, and any additional fees. They should also clarify the process for inconclusive results or situations in which repeat testing is considered.
Before deciding, it is helpful to compare the potential benefits and limitations of testing with the alternative of proceeding with IVF without PGT-A.
Questions to Ask Your Fertility Specialist
Before choosing embryo genetic testing, consider asking:
Why might PGT-A be appropriate in my case?
What benefits can I realistically expect from testing?
What are the limitations of the test?
How are mosaic or inconclusive results handled?
What is the total cost, including biopsy and laboratory fees?
How could testing affect the timing of my embryo transfer?
These questions can help patients understand their options and make decisions based on their medical history rather than general success-rate claims.
People exploring different paths to parenthood can also learn more about surrogacy and fertility treatment options and the questions to consider before beginning their journey.
Final Thoughts
PGT-A can provide useful information about the chromosome status of embryos during IVF, but it is not necessary or beneficial for every patient. Its value depends on individual circumstances, the number of embryos available, reproductive history, and treatment goals.
Discussing the advantages, limitations, costs, and alternatives with a qualified fertility specialist is the best way to decide whether PGT-A fits your treatment plan. Informed decisions and realistic expectations can help patients approach fertility treatment with greater clarity.
This article is for educational purposes only and is not a substitute for individualized medical advice.
